EarningsQ2 2023 Earnings Report

BeOne Medicines (ONCN) Q2 2023 Earnings Report

0 Followers

MX:ONCN Q2 2023 EPS Results

Actual EPS-$66.94

Consensus EPS-$61.81

Beat/MissMissed by -$5.13

One Year Ago EPS-$102.25

Actual Revenue$10.82B

Expected Revenue$9.22B

Beat/MissBeat by +$1.61B

YoY Revenue Growth+73.15%

QuarterQ2 2023

Date08/25/2023

TimeTBA

Conference CallFriday, August 25, 2023

MX:ONCN Upcoming Earnings

BeOne Medicines's next earnings date is estimated for October 31, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 31, 2026	2026 (Q3)	34.69 / -	20.046	―
Aug 05, 2026	2026 (Q2)	30.55 / 37.70	16.736	125.27% (+20.97)
May 06, 2026	2026 (Q1)	17.80 / 36.05	0	―
Feb 26, 2026	2025 (Q4)	22.88 / 11.03	-26.299	141.96% (+37.33)
Nov 06, 2025	2025 (Q3)	15.65 / 20.05	-21.15	194.78% (+41.20)
Aug 06, 2025	2025 (Q2)	7.12 / 16.74	-21.15	179.13% (+37.89)
May 07, 2025	2025 (Q1)	-10.56 / 0.00	-44.323	―
Feb 27, 2025	2024 (Q4)	-18.61 / -26.30	-64.921	59.49% (+38.62)
Nov 12, 2024	2024 (Q3)	-20.49 / -21.15	36.966	-157.21% (-58.12)
Aug 26, 2024	2024 (Q2)	-40.26 / -21.15	-66.944	68.41% (+45.79)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed